powerpoint presentation

Download Report

Transcript powerpoint presentation

A Strategic Research Agenda for
Europe in the field of illicit drugs
Priorities for socio-economic and humanities
research
HDG Brussels - December 10, 2014
Edvard Beem - Co-director ZonMw, The Netherlands
Aziz Naji - Programme Manager BELSPO, Belgium
Composition of ERANID
ERANID is an ERA-NET consisting of 11 funding agencies from
6 European countries:
•
•
•
•
•
•
Belgium
France
Italy
The Netherlands
Portugal
United Kingdom
ERANID cooperates with the EMCDDA and with the Pompidou
Group
13/04/2015
www.eranid.eu
2
European Research Area Network on Illicit
Drugs
Aims:
• To improve cooperation in drug research and in drug
research policy
• To – in the end – enable organisations to take well founded
policy decisions in demand and supply issues (evidence
based policy)
Methods:
• To fund joint multidisciplinary research projects through
Joint Transnational Calls
• To improve implementation of and accessibility to research
findings
13/04/2015
www.eranid.eu
3
First common call ERANID
ERANID aims to launch its first Joint Transnational Call for
proposals in 2015.
Scientists from participating countries and different disciplines
will be invited to submit proposals for collaborative research.
13/04/2015
www.eranid.eu
4
Aim of the ERANID SRA
• To identify key research themes for drug related research
that can fill knowledge gaps and can help to improve
practice and policy.
• To form the basis for calls for proposals.
13/04/2015
www.eranid.eu
5
Way of work
1. Research needs
A wide consultation of stakeholders in the six ERANID
countries, through:
- ERANID survey
- National consultations
2. Comparative analysis of research (2010 – 2013)
Summary of the comparative analysis of research across
Europe: information on National and European research policy
frameworks, funding mechanisms, and on identified gaps in
research areas and the disciplines involved.
13/04/2015
www.eranid.eu
6
Way of work
3. Draft research themes discussed at Lisbon
International Invitational Conference
(October 1&2, 2014)
4. Drafting SRA, based on all previous results
5. Draft SRA discussed in Advisory Committee
6. Draft SRA approved by Network Steering Committee
13/04/2015
www.eranid.eu
7
13/04/2015
www.eranid.eu
8
SRA: research area 1
Understanding drug use through the life course
•
•
•
drug use and related consequences throughout the life
course
adopting a dynamic perspective on the relationship
between social, environmental, cultural, biological and
behavioural factors and drug use pathways and
consequences
use across the whole population including non-drug users,
those with limited drug use history, frequent drug users
and those who have experienced dependence issues
without coming to the attention of services
13/04/2015
www.eranid.eu
9
SRA: research area 2
Improving wellbeing: responding to drug use and its
consequences
•
•
improving knowledge and understanding of effective
health and social responses and how to measure the
impact of programmes and interventions. This includes
prevention, risk and harm reduction, treatment and social
responses.
mechanisms underlying intervention effects
13/04/2015
www.eranid.eu
10
SRA: research area 3
A better understanding of drug markets, supply and
supply reduction responses
• assessment of the impact of drug markets and supply
reduction responses on individuals, communities and
society
• help improve understanding of the relationship between
supply and demand
• involving drug users in research
• exploring the issue at a local and regional level
13/04/2015
www.eranid.eu
11
SRA: research area 4
Policy analysis: implementation and impact
• Focus on general policy rather than specific interventions
• To identify appropriate tools and measures for assessing
the impact of policy
• To explore issues of implementation and governance
13/04/2015
www.eranid.eu
12
SRA: 4 common themes
1. Measurement and methodology
This theme focuses on issues of measurement and the
development of innovative methodological approaches for
improving knowledge on drug issues.
2. Key actor perspective
This theme takes the perspective of key actors such as
drug users and advocates research based on user or
individual perspectives.
13/04/2015
www.eranid.eu
13
SRA: 4 common themes
3. The social environment
This theme encourages research that situates drug use
and its consequences within the context of the social
environment.
4. Understanding the impact and opportunities of
communication technologies
This theme aims to further our understanding of how
communication technologies influence the drug situation
and how they can be harnessed to improve responses to
the drug situation, including the improvement of research
methodologies.
13/04/2015
www.eranid.eu
14
Thank you for your attention!
Go to our website
www.eranid.eu
to sign up for the newsletter and to find out
how to join our consortium
13/04/2015
www.eranid.eu
15